A method of producing vital chemical building blocks for use in the pharmaceutical and agrochemical industries that mimics how plants manufacture them has been developed by University of Warwick scientists.

Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the University of Warwick.

Dr Freya Harrison, Associate Professor in the School of Life Sciences at the University of Warwick., has won the WH Prize 2021 for her work in translating medieval literature and medical texts to uncover ancient antimicrobial recipes.

Combining data on antibody prevalence, PCR test results, genomic surveillance and population mobility from smartphones has allowed infectious disease modellers to explain the evolution of the first three Covid-19 waves that have affected Kenya since the start of the pandemic.

A University of Warwick researcher investigating Alzheimer’s disease has been named as one of four new Race Against Dementia Fellows, with the opportunity to receive support from not only leading scientists studying dementia, but also experts in innovation and problem solving from the world of Formula 1.